CLINICAL_TRIALS
trial_result
· 2022-10-21
Clinical Trial Update: Safety and Efficacy Study of PRV111 in Subjects With Oral Squamous Cell Carcinoma [Phase 1, Phase 2]
Summary
Phase 1/2 trial evaluating PRV111 in oral squamous cell carcinoma has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Privo Technologies | Conditions: Oral Squamous Cell Carcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-10-21